2025
Filter by topic
22-May-25
AGM trading update for the four months ended 30 April 2025
Corporate Financial Performance20-May-25
Advancing subcutaneous infusion therapy for patients through innovation and partnerships
Corporate Infusion Care25-Apr-25
Convatec receives regulatory approval for ConvaNiox™
Corporate Advanced Wound Care11-Apr-25
Convatec welcomes postponement of Local Coverage Determinations (LCDs) on skin substitutes until January 2026
Corporate Advanced Wound Care31-Mar-25
Convatec announces exclusive collaboration with largest Wound, Ostomy and Continence professional nursing organisation
Corporate Ostomy Care18-Mar-25
Convatec showcases its strongest wound care innovation pipeline ever at EWMA
Corporate Advanced Wound Care26-Feb-25
Annual results for the year ended 31 December 2024
Corporate Financial Performance26-Jan-25
Convatec welcomes the postponement of Local Coverage Determinations (LCDs) on skin substitutes in the United States
Corporate Advanced Wound Care